Order Article Reprints

Giner-Galvañ V, Pomares-Gómez FJ, Quesada JA, Rubio-Rivas M, Tejada-Montes J, Baltasar-Corral J, Taboada-Martínez ML, Sánchez-Mesa B, Arnalich-Fernández F, Del Corral-Beamonte E, et al. C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines. 2022; 10(6):1393. https://doi.org/10.3390/biomedicines10061393

Giner-Galvañ, Vicente, Francisco José Pomares-Gómez, José Antonio Quesada, Manuel Rubio-Rivas, Javier Tejada-Montes, Jesús Baltasar-Corral, María Luisa Taboada-Martínez, Blanca Sánchez-Mesa, Francisco Arnalich-Fernández, Esther Del Corral-Beamonte, and et al. 2022. "C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19" Biomedicines 10, no. 6: 1393. https://doi.org/10.3390/biomedicines10061393

Giner-Galvañ, V., Pomares-Gómez, F. J., Quesada, J. A., Rubio-Rivas, M., Tejada-Montes, J., Baltasar-Corral, J., Taboada-Martínez, M. L., Sánchez-Mesa, B., Arnalich-Fernández, F., Del Corral-Beamonte, E., López-Sampalo, A., Pesqueira-Fontán, P. M., Fernández-Garcés, M., Gómez-Huelgas, R., Ramos-Rincón, J. M., & on behalf of the SEMI-COVID-19 Network. (2022). C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines, 10(6), 1393. https://doi.org/10.3390/biomedicines10061393